R Sugimoto Selected Research

R Sugimoto Research Topics

Disease

5	Fibrosis (Cirrhosis) 11/2001 - 05/2000
3	Inflammation (Inflammations) 10/2008 - 03/2000
3	Chronic Hepatitis C 02/2008 - 03/2006
3	Liver Diseases (Liver Disease) 07/2006 - 05/2000
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 11/2016
2	Reperfusion Injury 11/2012 - 10/2007
2	Iron Overload 07/2008 - 02/2008
2	Infections 03/2001 - 09/2000
1	Anorexia 12/2019
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2019
1	Nausea 12/2019
1	Vomiting 12/2019
1	Acute Lung Injury 11/2012
1	Ischemia 10/2008
1	Liver Neoplasms (Liver Cancer) 07/2008
1	Virus Diseases (Viral Diseases) 07/2006
1	Weight Loss (Weight Reduction) 11/2001
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 03/2001
1	Hyperopia (Hypermetropia) 03/2001
1	Myopia 03/2001
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2001
1	Hepatitis 09/2000
1	Shock 06/2000
1	Asthma (Bronchial Asthma) 03/2000

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 11/2016
3	InterferonsIBA 07/2006 - 03/2001
3	Dimethylnitrosamine (Nitrosodimethylamine)IBA 11/2001 - 04/2001
3	CollagenIBA 11/2001 - 04/2001
3	Hydroxyproline (4 Hydroxyproline)IBA 11/2001 - 04/2001
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 11/2016
2	IronIBA 07/2008 - 02/2008
2	Ribavirin (Virazole)FDA LinkGeneric 07/2006 - 03/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 07/2006 - 09/2000
2	CytokinesIBA 03/2001 - 03/2000
1	Gemcitabine FDA Link 12/2019
1	NitritesIBA 11/2012
1	HydrogenIBA 10/2008
1	AntioxidantsIBA 10/2008
1	Mitogen-Activated Protein KinasesIBA 10/2007
1	Carbon MonoxideIBA 10/2007
1	p38 Mitogen-Activated Protein KinasesIBA 10/2007
1	low density lipoprotein inhibitorIBA 07/2006
1	BezafibrateIBA 07/2006
1	RNA (Ribonucleic Acid)IBA 07/2006
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2006
1	Antiviral Agents (Antivirals)IBA 03/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2001
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 11/2001
1	Collagen Type I (Type I Collagen)IBA 07/2001
1	pirfenidoneIBA 07/2001
1	rho-Associated KinasesIBA 04/2001
1	Y 27632IBA 04/2001
1	Nicotinic AntagonistsIBA 03/2001
1	Proteins (Proteins, Gene)FDA Link 03/2001
1	Cholinergic ReceptorsIBA 03/2001
1	CholesterolIBA 03/2001
1	MecamylamineIBA 03/2001
1	LeptinIBA 03/2001
1	SteroidsIBA 03/2001
1	Chlorisondamine (Chlorisondamine Chloride)IBA 03/2001
1	ImmunosorbentsIBA 03/2001
1	EnzymesIBA 03/2001
1	AntigensIBA 09/2000
1	ebselenIBA 06/2000
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2000
1	Tyrosine (L-Tyrosine)FDA Link 05/2000
1	Phosphotransferases (Kinase)IBA 05/2000
1	Platelet-Derived Growth FactorIBA 05/2000
1	6,7-dimethoxy-2-phenylquinoxalineIBA 05/2000
1	tyrosine receptor (receptor, tyrosine)IBA 05/2000
1	Interleukin-13IBA 03/2000
1	Interleukin-4 (Interleukin 4)IBA 03/2000
1	Immunoglobulin E (IgE)IBA 03/2000
1	Interleukin-13 Receptor alpha1 SubunitIBA 03/2000
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2000

Therapy/Procedure

3	Therapeutics 11/2016 - 03/2001
2	Drug Therapy (Chemotherapy) 01/2017 - 11/2016
1	Lung Transplantation 11/2012
1	Transplantation 10/2008